MECASERMIN

mecasermin 10 mg/mL injection, 4 mL vial

MECASERMIN (13116H)

mecasermin 10 mg/mL injection, 4 mL vial
13116H
Body System:
Manner of administration:Injection
S100 Growth Hormone Programme
Authority Required

Restriction

Indication: Severe growth failure with primary insulin-like growth factor-1 deficiency
Treatment phase: Initial treatment

Restriction

Indication: Severe growth failure with primary insulin-like growth factor-1 deficiency
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 5 DPMQ: $1,072.88 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Increlex